2014
DOI: 10.1016/j.endonu.2014.02.003
|View full text |Cite
|
Sign up to set email alerts
|

Evolución clínica a 5 años desde el inicio de la insulinoterapia en pacientes con diabetes tipo 2 en España: resultados del estudio EDIN

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 24 publications
0
0
1
Order By: Relevance
“…Different studies conducted in patients with T1DM have shown that a greater frequency of SMBG is associated with greater decreases in HbA 1c values. 8,15---17 In patients with T2DM, for whom SMBG is well established both in this country 18 and elsewhere, the results differ to a greater or lesser extent. Thus, Harris,19 in an observational study including patients with DM treated with insulin or oral antidiabetics, did not find that an increased frequency of SMBG improved metabolic control.…”
Section: Discussioncontrasting
confidence: 54%
“…Different studies conducted in patients with T1DM have shown that a greater frequency of SMBG is associated with greater decreases in HbA 1c values. 8,15---17 In patients with T2DM, for whom SMBG is well established both in this country 18 and elsewhere, the results differ to a greater or lesser extent. Thus, Harris,19 in an observational study including patients with DM treated with insulin or oral antidiabetics, did not find that an increased frequency of SMBG improved metabolic control.…”
Section: Discussioncontrasting
confidence: 54%